SLEEP-COPE: Sleep Intervention for Oppositional Children

Description

Children with Oppositional Defiant Disorder (ODD) are at risk for insomnia, arousal dysfunction, mood problems, and noncompliance. Cognitive behavioral treatment for insomnia (CBT-I) holds promise for improving insomnia and related concerns. Telehealth delivery will reduce the burden of in-person sessions, particularly in areas where there is low mental healthcare access. Telehealth CBT-I is efficacious in adults and children but has not been tested in children with ODD. The proposed trial is the next logical step - development and iterative testing of SLEEP-COPE, a brief dyadic telehealth CBT-I for children with ODD and their parents.

Conditions

Insomnia Chronic, Oppositional Defiant Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

Children with Oppositional Defiant Disorder (ODD) are at risk for insomnia, arousal dysfunction, mood problems, and noncompliance. Cognitive behavioral treatment for insomnia (CBT-I) holds promise for improving insomnia and related concerns. Telehealth delivery will reduce the burden of in-person sessions, particularly in areas where there is low mental healthcare access. Telehealth CBT-I is efficacious in adults and children but has not been tested in children with ODD. The proposed trial is the next logical step - development and iterative testing of SLEEP-COPE, a brief dyadic telehealth CBT-I for children with ODD and their parents.

SLEEP-COPE: Sleep Enhancement and Effective Parenting for Children With Oppositional and Problematic Expressions

SLEEP-COPE: Sleep Intervention for Oppositional Children

Condition
Insomnia Chronic
Intervention / Treatment

-

Contacts and Locations

Tampa

University of South Florida, Tampa, Florida, United States, 33620-8100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Child ages 8-12 with ODD (prior diagnosis) and insomnia
  • 2. Child and parent English proficiency.
  • 1. complaints of difficulties falling asleep, staying asleep, or early morning awakening by child report or parent observation for 3+ mos
  • 2. daytime dysfunction (mood, cognitive, social, academic) due to insomnia
  • 3. baseline diaries and actigraphy indicate \>30 mins. of sleep onset latency, wake after sleep onset, or early morning awakening (time between last awakening and out of bed time) on 6+ nights
  • 1. Parent unable to provide informed consent or child unable to provide assent
  • 2. Family unwilling to accept random assignment
  • 3. Child/parent participation in another randomized research project
  • 4. Parent unable to complete forms or implement treatment procedures due to cognitive impairment
  • 5. Child untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias)
  • 6. Child psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin
  • 7. Child participation in non-pharmacological treatment (including CBT) for sleep outside current trial
  • 8. Parent report of inability to undergo Holter Monitoring or actigraphy (e.g., extreme sensitivity, behavioral outbursts)
  • 9. Other conditions adversely affecting trial participation

Ages Eligible for Study

8 Years to 12 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of South Florida,

Study Record Dates

2025-02-01